Bayer Wins First U.S. Trial Over Roundup Since Supreme Court Ruling
By Adria Calatayud
A Missouri Circuit Court sided with Bayer's Monsanto business in a case over its Roundup weedkiller, handing the company a win in the first trial since the U.S. Supreme Court ruled in its favor in June.
Bayer said late Thursday that the court jury ruled for Monsanto on the design defect, fraud, and negligence claims that each of the three plaintiffs pursued.
The verdict came after the company won its Supreme Court challenge against claims that it failed to warn consumers that Roundup causes cancer and as it pursues a $7.25 billion settlement as part of a plan to move past long-running legal battles.
The company said it would continue to back the safety of its glyphosate-based herbicides and defend its products in any remaining litigation.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
October 30, 2026 03:39 ET (07:39 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
What 7 Key Market Indicators Are Telling Investors Right Now
Don’t Overlook the Income Side of Fixed Income
United States